Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Uterine Cervical Neoplasms
×
tisotumab vedotin
×
Clear all
Filters
3
NCT06459180
2026-03-13
TroFuse-020
Merck Sharp & Dohme LLC
Phase 3
Recruiting
686 enrolled
NCT04697628
2026-02-24
innovaTV 301
Seagen Inc.
Phase 3
Completed
502 enrolled
18 charts
1 FDA